Study of VDPHL01 for women with hair thinning
Part of Skin clinical trials.
This trial tests whether a new oral treatment, VDPHL01, can help women with mild to moderate pattern hair loss. It also checks for side effects and how the drug works in the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 65 years old.
- You have been diagnosed with mild to moderate pattern hair loss (androgenetic alopecia).
- You are in good overall health with normal liver and kidney function.
- You must keep your hair at least a quarter inch long and not change your hairstyle, color, or hair products during the study.
- You are willing to take the study drug by mouth and get a tiny dot tattoo on your scalp for photos.
- You have not used certain hair loss treatments, hormone therapies, or had scalp procedures in the past few months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication called ABS-201 for hair loss. It will first see if the medicine is safe in healthy people, then test if it helps those with male or female pattern baldness.
This trial tests an investigational drug called OLX72021 for male pattern hair loss (androgenetic alopecia). It aims to see if the drug is safe and effective in healthy men with mild to moderate hair loss.
This study tests an experimental treatment called EPI-001 for androgenetic alopecia—the most common type of hair loss affecting men and women. Researchers will measure how well it works by tracking hair growth over time using special photography and scalp analysis.
This trial tests a new treatment (DA-001) to reduce hair shedding and help hair grow back in people with telogen effluvium—a temporary hair loss condition. The treatment is applied directly to the scalp, and participants will be followed to see how well it works.
This study tests two new topical treatments (DA-002 and DA-005) for hair loss in people with pattern baldness. The goal is to see if they can help hair grow back.
This trial tests a once-daily scalp solution called KX-826 to help men with typical male pattern baldness grow hair and slow hair loss. It compares the active solution to a placebo (no active ingredient) to see if it works and is safe.
Hear when a new Androgenetic Alopecia (AGA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.